Boehringer Ingelheim's new 120 million euro Investment in Greece
The research-driven biopharmaceutical company Boehringer Ingelheim announced that it will invest 120 million euros to expand and upgrade its plant in Greece.
- Published in Greece
The research-driven biopharmaceutical company Boehringer Ingelheim announced that it will invest 120 million euros to expand and upgrade its plant in Greece.
The government is proceeding with the reduction of VAT on drugs and services related to cancer, government spokesperson Stelios Petsas said during a press briefing on Tuesday.
The Greek Health Ministry stated today that the nation has halted the export of 25 types of pharmaceuticals, after pharmacists have reported challenges in acquiring various medicines.